Prolia (Denosumab) Travel & Timezone-Shift Protocols

At a glance

  • Dose and interval / 60 mg subcutaneously every 6 months [1]
  • Who gives it / A healthcare provider, into the upper arm, upper thigh or abdomen [1]
  • Time zones / A few hours of clock shift do not matter against a 6-month interval
  • Late dose / The label says to give it as soon as the patient is available, then every 6 months from that date [1]
  • Calcium check / The label calls for calcium, phosphorus and magnesium checks 10 to 14 days after the injection in people without advanced kidney disease who are prone to low calcium. For advanced kidney disease it calls for weekly calcium checks for the first month, then monthly [1]
  • After stopping / New vertebral fractures reported as early as 7 months after the last dose [1]

Does a time-zone shift change when Prolia is due?

No. Prolia is dosed once every 6 months, so the interval is counted in months, not hours [1]. It is also administered by a healthcare provider [1], so the schedule is an appointment rather than a self-injection routine.

What the label says when a dose falls during a trip

If a dose is missed, the Prolia label says to give the injection as soon as the patient is available, then schedule subsequent doses every 6 months from that injection [1]. For example, a dose given two weeks late on return moves the whole schedule forward two weeks. The next one is due 6 months from the actual injection date, not the original plan.

Why the gap after the last dose matters

Denosumab binds RANKL and blocks osteoclast activity, and the effect reverses when dosing stops. The label states that bone turnover rises above pretreatment levels about 9 months after the last Prolia dose and returns to pretreatment values by about 24 months [1]. New vertebral fractures have been reported as early as 7 months after the last dose, on average 19 months, and the label tells prescribers to transition to an alternative antiresorptive therapy if Prolia is discontinued [1]. FDA's safety communication says fracture risk, including in the spine, is increased after stopping, skipping or delaying Prolia [4].

In a post hoc analysis of 1,001 participants who stopped denosumab during FREEDOM or its extension, the vertebral fracture rate rose from 1.2 per 100 participant-years on treatment to 7.1 off treatment [2]. That analysis was not randomized.

Calcium checks around a dose taken away from home

The Prolia label splits patients into two monitoring groups. For people without advanced kidney disease who are prone to hypocalcemia (for example after thyroid or parathyroid surgery, with malabsorption or small bowel excision, or on other calcium-lowering drugs), it calls for calcium, phosphorus and magnesium checks 10 to 14 days after the injection [1]. For people with advanced chronic kidney disease (eGFR below 30), including dialysis, it calls for serum calcium checks weekly for the first month after the injection and monthly thereafter [1]. The label also says to instruct patients to take 1,000 mg calcium and at least 400 IU vitamin D daily [1].

In FREEDOM, serum calcium reached its low point about 10 days after a dose in people with normal kidney function [1]. A trip that overlaps the 10 to 14 days after an injection overlaps the window in which the label calls for those checks.

Frequently asked questions

Does flying across time zones change when my next Prolia dose is due?
No. Prolia is given once every 6 months, so hours of clock shift do not alter a 6-month interval [1]. A healthcare provider administers it [1], so the date to count from is the last actual injection.
What happens if my injection is due while I am abroad?
The label says to give it as soon as the patient is available and to count every 6 months from that date [1]. FDA says fracture risk is increased after stopping, skipping or delaying Prolia [4].
How do I know an injection abroad is the right product?
Prolia and Xgeva have different uses and schedules: Prolia is 60 mg every 6 months for osteoporosis and bone loss, while Xgeva is 120 mg every 4 weeks for cancer-related bone conditions [1][3]. Both labels say patients should not receive other denosumab products at the same time [1][3]. The Prolia label also says pregnancy must be ruled out before administration [1].

References

  1. U.S. National Library of Medicine, DailyMed. Prolia injection (denosumab) prescribing information. Prolia injection (denosumab) label
  2. Cummings SR, Ferrari S, Eastell R, Gilchrist N, Jensen JB, McClung M, et al. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension. J Bone Miner Res. 2018;33(2):190-198. Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its Extension
  3. U.S. National Library of Medicine, DailyMed. Xgeva injection (denosumab) prescribing information. Xgeva injection (denosumab) label
  4. U.S. Food and Drug Administration. FDA adds Boxed Warning for increased risk of severe hypocalcemia in patients with advanced chronic kidney disease taking osteoporosis medicine Prolia (denosumab). Drug Safety Communication, 2024. FDA Drug Safety Communication
Evidence overview for denosumab: Prolia (Denosumab) Travel & Timezone-Shift Protocols